Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
25
CSLLY Quote, Financials, Valuation and Earnings
Last price:
$89.61
Seasonality move
:
3.8%
Day range:
$86.02 - $90.03
52-week range:
$83.31 - $109.00
Dividend yield:
1.49%
P/E ratio:
32.57x
P/S ratio:
5.86x
P/B ratio:
4.95x
Volume:
90.5K
Avg. volume:
95.8K
1-year change:
-7.48%
Market cap:
$85.9B
Revenue:
$14.7B
EPS (TTM):
$2.73
Analysts' Opinion
-
Consensus RatingCSL has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, CSL has an estimated downside of -- from its current price of $88.75.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $88.75.
Fair Value
-
According to the consensus of 0 analysts, CSL has -- downside to fair value with a price target of -- per share.
CSLLY vs. S&P 500
-
Over the past 5 trading days, CSL has underperformed the S&P 500 by -2.5% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CSL does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CSL has grown year-over-year revenues for 0 quarters straight. In the most recent quarter CSL reported revenues of --.
Earnings Growth
-
CSL has grown year-over-year earnings for 0 quarters straight. In the most recent quarter CSL reported earnings per share of --.
Enterprise value:
96.8B
EV / Invested capital:
--
Price / LTM sales:
5.86x
EV / EBIT:
25.52x
EV / Revenue:
6.59x
PEG ratio (5yr expected):
2.41x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
20.46x
Gross Profit (TTM):
$7.6B
Return On Assets:
7.11%
Net Income Margin (TTM):
17.99%
Return On Equity:
14.06%
Return On Invested Capital:
8.85%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2018-06-30 | 2019-06-30 | |
| Income Statement | ||||||
| Revenue | $6.6B | $7.6B | $8.5B | -- | -- | |
| Gross Profit | $3.3B | $4.1B | $4.7B | -- | -- | |
| Operating Income | $1.3B | $1.8B | $2.1B | -- | -- | |
| EBITDA | $1.9B | $2.7B | $2.9B | -- | -- | |
| Diluted EPS | $1.47 | $1.90 | $2.11 | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.4B | $7.4B | $16.5B | $9.3B | $10.8B | |
| Total Assets | $15.5B | $18.2B | $28.3B | $36.2B | $38B | |
| Current Liabilities | $2.1B | $3.1B | $7.1B | $4.6B | $5B | |
| Total Liabilities | $8.9B | $9.8B | $13.8B | $18.4B | $18.6B | |
| Total Equity | $6.5B | $8.4B | $14.6B | $17.8B | $19.4B | |
| Total Debt | $5.9B | $4.6B | $8.3B | $10.5B | $10.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 1996-09-30 | 1997-09-30 | 1998-09-30 | 1997-09-30 | 1998-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $398M | $303M | |
| Cash From Investing | -- | -- | -- | -$169M | $282M | |
| Cash From Financing | -- | -- | -- | -$237M | -$547M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CSLLY
Sector
Market Cap
$85.9B
$46.1M
Price % of 52-Week High
81.42%
46.02%
Dividend Yield
1.49%
0%
Shareholder Yield
1.78%
-0.6%
1-Year Price Total Return
-7.49%
-30.52%
Beta (5-Year)
0.745
0.772
Dividend yield:
1.49%
Annualized payout:
$1.24
Payout ratio:
47.92%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$87.56
200-day SMA
Sell
Level
$95.81
Bollinger Bands (100)
Sell
Level
91.3 - 102.1
Chaikin Money Flow
Buy
Level
15.3M
20-day SMA
Sell
Level
$89.29
Relative Strength Index (RSI14)
Sell
Level
45.28
ADX Line
Sell
Level
14.43
Williams %R
Neutral
Level
-32.254
50-day SMA
Sell
Level
$92.44
MACD (12, 26)
Sell
Level
-1.36
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
1.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.5565)
Buy
CA Score
(Annual)
Level (-0.0955)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.6478)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world’s second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
Stock Forecast FAQ
In the current month, CSLLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CSLLY average analyst price target in the past 3 months is --.
-
Where Will CSL Stock Be In 1 Year?
According to analysts, the consensus estimate is that CSL share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About CSL?
Analysts are divided on their view about CSL share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CSL is a Sell and believe this share price will rise from its current level to --.
-
What Is CSL's Price Target?
The price target for CSL over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CSLLY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CSL is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CSLLY?
You can purchase shares of CSL via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CSL shares.
-
What Is The CSL Share Price Today?
CSL was last trading at $89.61 per share. This represents the most recent stock quote for CSL. Yesterday, CSL closed at $88.75 per share.
-
How To Buy CSL Stock Online?
In order to purchase CSL stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
